Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
April 29, 2006
Assessment of a virtual interventional simulator trainer
Max Berry, Ted Lystig, Richard Reznick, et al.
Respiratory Medicine
|
April 27, 2010
Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial
Donald Tashkin, Bartolome Celli, Steven Kesten, et al.
Cardiovascular and Interventional Radiology
|
January 18, 2007
Porcine transfer study: virtual reality simulator training compared with porcine training in endovascular novices
Max Berry, Ted Lystig, Jonathan Beard, et al.
Respiratory Research
|
January 12, 2011
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
Nicola A Hanania, Amir Sharafkhaneh, Bartolome Celli, et al.
The New England Journal of Medicine
|
August 24, 2007
Effects of bariatric surgery on mortality in Swedish obese subjects
Lars Sjöström, Kristina Narbro, C David Sjöström, et al.
Journal of the American College of Cardiology
|
March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
The New England Journal of Medicine
|
January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
Julian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Circulation
|
November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Daniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
The New England Journal of Medicine
|
June 29, 2026
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
Ravi Savarirayan, Julie Hoover-Fong, Melita Irving, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
April 29, 2006
Assessment of a virtual interventional simulator trainer
Max Berry, Ted Lystig, Richard Reznick, et al.
Respiratory Medicine
|
April 27, 2010
Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial
Donald Tashkin, Bartolome Celli, Steven Kesten, et al.
Cardiovascular and Interventional Radiology
|
January 18, 2007
Porcine transfer study: virtual reality simulator training compared with porcine training in endovascular novices
Max Berry, Ted Lystig, Jonathan Beard, et al.
Respiratory Research
|
January 12, 2011
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
Nicola A Hanania, Amir Sharafkhaneh, Bartolome Celli, et al.
The New England Journal of Medicine
|
August 24, 2007
Effects of bariatric surgery on mortality in Swedish obese subjects
Lars Sjöström, Kristina Narbro, C David Sjöström, et al.
Journal of the American College of Cardiology
|
March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
The New England Journal of Medicine
|
January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
Julian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Circulation
|
November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Daniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
The New England Journal of Medicine
|
June 29, 2026
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
Ravi Savarirayan, Julie Hoover-Fong, Melita Irving, et al.
Page
of 1